Authors:
Torn, C
Landin-Olsson, M
Lernmark, A
Schersten, B
Ostman, J
Arnqvist, HJ
Bjork, E
Blohme, G
Bolinder, J
Eriksson, J
Littorin, B
Nystrom, L
Sundkvist, G
Citation: C. Torn et al., Combinations of beta cell specific autoantibodies at diagnosis of diabetesin young adults reflects different courses of beta cell damage, AUTOIMMUN, 33(2), 2001, pp. 115-120
Authors:
Littorin, B
Bjork, E
Sundkvist, G
Blohme, G
Nystrom, L
Bolinder, J
Carlson, A
Eriksson, JW
Landin-Olsson, M
Schersten, B
Ostman, J
Wibell, L
Arnqvist, HJ
Citation: B. Littorin et al., Family characteristics and life events before the onset of autoimmune type1 diabetes in young adults - A nationwide study, DIABET CARE, 24(6), 2001, pp. 1033-1037
Authors:
Borg, H
Gottsater, A
Landin-Olsson, M
Fernlund, P
Sundkvist, G
Citation: H. Borg et al., High levels of antigen-specific islet antibodies predict future beta-cell failure in patients with onset of diabetes in adult age, J CLIN END, 86(7), 2001, pp. 3032-3038
Authors:
Torn, C
Landin-Olsson, M
Ostman, J
Schersten, B
Arnqvist, H
Blohme, G
Bjork, E
Bolinder, J
Eriksson, J
Littorin, B
Nystrom, L
Sundkvist, G
Lernmark, A
Citation: C. Torn et al., Glutamic acid decarboxylase antibodies (GADA) is the most important factorfor prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds, DIABET M R, 16(6), 2000, pp. 442-447
Authors:
Marcovina, SM
Landin-Olsson, M
Essen-Moller, A
Palmer, JP
Lernmark, A
Citation: Sm. Marcovina et al., Evaluation of a novel radioimmunoassay using I-125-labelled human recombinant GAD65 for the determination of glutamic acid decarboxylase (GAD65) autoantibodies, INT J CL L, 30(1), 2000, pp. 21-26
Authors:
Lowe, RM
Graham, J
Sund, G
Kockum, I
Landin-Olsson, M
Schaefer, JB
Torn, C
Lernmark, A
Dahlquist, G
Citation: Rm. Lowe et al., The length of the CTLA-4 microsatellite (AT)(N)-repeat affects the risk for type 1 diabetes, AUTOIMMUN, 32(3), 2000, pp. 173-180
Authors:
Ostman, J
Landin-Olsson, M
Torn, C
Palmer, J
Lernmark, A
Arnqvist, H
Bjork, E
Bolinder, J
Blohme, G
Eriksson, J
Littorin, B
Nystrom, L
Schersten, B
Sundkvist, G
Wibell, L
Citation: J. Ostman et al., Ketoacidosis in young adults is not related to the islet antibodies at thediagnosis of Type 1 diabetes mellitus - a nationwide study, DIABET MED, 17(4), 2000, pp. 269-274
Authors:
Torn, C
Landin-Olsson, M
Lernmark, A
Palmer, JP
Arnqvist, HJ
Blohme, G
Lithner, F
Littorin, B
Nystrom, L
Schersten, B
Sundkvist, G
Wibell, L
Ostman, J
Citation: C. Torn et al., Prognostic factors for the course of beta cell function in autoimmune diabetes, J CLIN END, 85(12), 2000, pp. 4619-4623
Authors:
Hampe, CS
Hammerle, LP
Bekris, L
Ortqvist, E
Kockum, I
Rolandsson, O
Landin-Olsson, M
Torn, C
Persson, B
Lernmark, A
Citation: Cs. Hampe et al., Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes, J CLIN END, 85(12), 2000, pp. 4671-4679
Authors:
Schranz, DB
Bekris, L
Landin-Olsson, M
Torn, C
Nilang, A
Toll, A
Sjostrom, J
Gronlund, H
Lernmark, A
Citation: Db. Schranz et al., Newly diagnosed latent autoimmune diabetes in adults (LADA) is associated with low level glutamate decarboxylase (GAD65) and IA-2 autoantibodies, HORMONE MET, 32(4), 2000, pp. 133-138
Authors:
Kockum, I
Sanjeevi, CB
Eastman, S
Landin-Olsson, M
Dahlquist, G
Lernmark, A
Citation: I. Kockum et al., Complex interaction between HLA DR and DO in conferring risk for childhoodtype 1 diabetes, EUR J IMM, 26(5), 1999, pp. 361-372
Authors:
Graham, J
Kockum, I
Sanjeevi, CB
Landin-Olsson, M
Nystrom, L
Sundkvist, G
Arnqvist, H
Blohme, G
Lithner, F
Littorin, B
Schersten, B
Wibell, L
Ostman, J
Lernmark, A
Breslow, N
Dahlquist, G
Citation: J. Graham et al., Negative association between type 1 diabetes and HLA DQB10602-DQA1*0102 is attenuated with age at onset, EUR J IMM, 26(2-3), 1999, pp. 117-127
Authors:
Lindberg, B
Carlsson, A
Ericsson, UB
Kockum, I
Lernmark, A
Landin-Olsson, M
Sundkvist, G
Ivarsson, SA
Citation: B. Lindberg et al., Prevalence of beta-cell and thyroid autoantibody positivity in schoolchildren during three-year follow-up, AUTOIMMUN, 31(3), 1999, pp. 175-185
Authors:
Landin-Olsson, M
Arnqvist, HJ
Blohme, G
Littorin, B
Lithner, F
Nystrom, L
Schersten, B
Sundkvist, G
Wibell, L
Ostman, J
Lernmark, A
Citation: M. Landin-olsson et al., Appearance of islet cell autoantibodies after clinical diagnosis of diabetes mellitus, AUTOIMMUN, 29(1), 1999, pp. 57-63
Authors:
Littorin, B
Sundkvist, G
Hagopian, W
Landin-Olsson, M
Lernmark, A
Ostman, J
Arnqvist, HJ
Blohme, G
Bolinder, J
Eriksson, JW
Lithner, F
Schersten, B
Wibell, L
Citation: B. Littorin et al., Islet cell and glutamic acid decarboxylase antibodies present at diagnosisof diabetes predict the need for insulin treatment - A cohort study in young adults whose disease was initially labeled as type 2 or unclassifiable diabetes, DIABET CARE, 22(3), 1999, pp. 409-412
Authors:
Lindberg, B
Ahlfors, K
Carlsson, A
Ericsson, UB
Landin-Olsson, M
Lernmark, A
Ludvigsson, J
Sundkvist, G
Ivarsson, SA
Citation: B. Lindberg et al., Previous exposure to measles, mumps, and rubella - But not vaccination during adolescence - Correlates to the prevalence of pancreatic and thyroid autoantibodies, PEDIATRICS, 104(1), 1999, pp. E121-E125
Authors:
Lindberg, B
Ivarsson, SA
Landin-Olsson, M
Sundkvist, G
Svanberg, L
Lernmark, A
Citation: B. Lindberg et al., Islet autoantibodies in cord blood from children who developed Type I (insulin-dependent) diabetes mellitus before 15 years of age, DIABETOLOG, 42(2), 1999, pp. 181-187